Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Intangibles (2022 - 2025)

Historic Change in Intangibles for Gyre Therapeutics (GYRE) over the last 4 years, with Q3 2025 value amounting to $15000.0.

  • Gyre Therapeutics' Change in Intangibles changed N/A to $15000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $813000.0 for FY2024, which is 107826.09% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Change in Intangibles of $15000.0 as of Q3 2025.
  • Gyre Therapeutics' 5-year Change in Intangibles high stood at $810000.0 for Q4 2024, and its period low was -$55.0 million during Q4 2022.
  • Over the past 4 years, Gyre Therapeutics' median Change in Intangibles value was $15000.0 (recorded in 2025), while the average stood at -$5.9 million.
  • In the last 5 years, Gyre Therapeutics' Change in Intangibles surged by 10000.18% in 2023 and then soared by 8090000.0% in 2024.
  • Gyre Therapeutics' Change in Intangibles (Quarter) stood at -$55.0 million in 2022, then soared by 100.0% to $1000.0 in 2023, then soared by 80900.0% to $810000.0 in 2024, then crashed by 98.15% to $15000.0 in 2025.
  • Its Change in Intangibles was $15000.0 in Q3 2025, compared to $23000.0 in Q2 2025 and $699000.0 in Q1 2025.